These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28125398)

  • 1. Successful Treatment of Human Plague with Oral Ciprofloxacin.
    Apangu T; Griffith K; Abaru J; Candini G; Apio H; Okoth F; Okello R; Kaggwa J; Acayo S; Ezama G; Yockey B; Sexton C; Schriefer M; Mbidde EK; Mead P
    Emerg Infect Dis; 2017 Mar; 23(3):553-5. PubMed ID: 28125398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Delaying Treatment on Efficacy of Ciprofloxacin and Levofloxacin in the African Green Monkey Model of Pneumonic Plague.
    Campbell JL; Fay MP; Lanning LL; Hewitt JA
    Clin Infect Dis; 2020 May; 70(70 Suppl 1):S60-S65. PubMed ID: 32435805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in mice.
    Russell P; Eley SM; Bell DL; Manchee RJ; Titball RW
    J Antimicrob Chemother; 1996 Apr; 37(4):769-74. PubMed ID: 8722542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The African Green Monkey Model of Pneumonic Plague and US Food and Drug Administration Approval of Antimicrobials Under the Animal Rule.
    Hewitt JA; Lanning LL; Campbell JL
    Clin Infect Dis; 2020 May; 70(70 Suppl 1):S51-S59. PubMed ID: 32435803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of Human Plague in Uganda, 2008-2016.
    Forrester JD; Apangu T; Griffith K; Acayo S; Yockey B; Kaggwa J; Kugeler KJ; Schriefer M; Sexton C; Ben Beard C; Candini G; Abaru J; Candia B; Okoth JF; Apio H; Nolex L; Ezama G; Okello R; Atiku L; Mpanga J; Mead PS
    Emerg Infect Dis; 2017 Sep; 23(9):1517-1521. PubMed ID: 28820134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synergistic action of some antibacterial agents in studies on albino mice with experimental plague caused by Fr- phenotype strain of the plague microbe].
    Shcherbaniuk AI; Liukshina EIu; Ryzhko IV; Smorodinova IuV
    Antibiot Khimioter; 2006; 51(1):7-10. PubMed ID: 16734358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic treatment of experimental pneumonic plague in mice.
    Byrne WR; Welkos SL; Pitt ML; Davis KJ; Brueckner RP; Ezzell JW; Nelson GO; Vaccaro JR; Battersby LC; Friedlander AM
    Antimicrob Agents Chemother; 1998 Mar; 42(3):675-81. PubMed ID: 9517950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Yersinia pestis and plague - an update].
    Stock I
    Med Monatsschr Pharm; 2014 Dec; 37(12):441-8; quiz 449. PubMed ID: 25643450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial.
    Randremanana RV; Raberahona M; Randria MJD; Rajerison M; Andrianaivoarimanana V; Legrand A; Rasoanaivo TF; Randriamparany R; Mayouya-Gamana T; Mangahasimbola R; Bourner J; Salam A; Gillesen A; Edwards T; Schoenhals M; Baril L; Horby P; Olliaro P
    Trials; 2020 Aug; 21(1):722. PubMed ID: 32807214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection.
    Russell P; Eley SM; Green M; Stagg AJ; Taylor RR; Nelson M; Beedham RJ; Bell DL; Rogers D; Whittington D; Titball RW
    J Antimicrob Chemother; 1998 Feb; 41(2):301-5. PubMed ID: 9533478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments.
    Vagima Y; Gur D; Erez N; Achdout H; Aftalion M; Levy Y; Zauberman A; Tidhar A; Gutman H; Lazar S; Israely T; Paran N; Melamed S; Brosh-Nissimov T; Chitlaru T; Sagi I; Mamroud E
    Sci Rep; 2020 Nov; 10(1):19116. PubMed ID: 33154422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Heme Oxygenase Expression by Cobalt Protoporphyrin Treatment Prevents Pneumonic Plague Caused by Inhalation of
    Willix JL; Stockton JL; Olson RM; Anderson PE; Anderson DM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the latest fluoroquinolones against experimental Yersinia pestis.
    Steward J; Lever MS; Russell P; Beedham RJ; Stagg AJ; Taylor RR; Brooks TJ
    Int J Antimicrob Agents; 2004 Dec; 24(6):609-12. PubMed ID: 15555886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lack of levofloxacin and moxyfloxacin efficacy in experimental plague of albino mice infected with nalidixic acid resistant pathogen (Nal(r))].
    Ryzhko IV; Trishina AV; Verkina LM
    Antibiot Khimioter; 2010; 55(11-12):22-4. PubMed ID: 21574421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two Distinct Yersinia pestis Populations Causing Plague among Humans in the West Nile Region of Uganda.
    Respicio-Kingry LB; Yockey BM; Acayo S; Kaggwa J; Apangu T; Kugeler KJ; Eisen RJ; Griffith KS; Mead PS; Schriefer ME; Petersen JM
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004360. PubMed ID: 26866815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin prophylaxis and therapy of Yersinia pestis infection.
    Shah PM
    J Antimicrob Chemother; 1998 Sep; 42(3):399. PubMed ID: 9786484
    [No Abstract]   [Full Text] [Related]  

  • 17. [Standardization of conditions for the evaluation of effectiveness of antibacterial drugs in pneumonic plague in sacred baboons].
    Romanov VE; Vasil'ev NT; Shabalin BA; Mironin AV; Paramonov VE
    Antibiot Khimioter; 1995 Jun; 40(6):23-30. PubMed ID: 8593090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bubonic and pneumonic plague - Uganda, 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jul; 58(28):778-81. PubMed ID: 19629028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cethromycin-mediated protection against the plague pathogen Yersinia pestis in a rat model of infection and comparison with levofloxacin.
    Rosenzweig JA; Brackman SM; Kirtley ML; Sha J; Erova TE; Yeager LA; Peterson JW; Xu ZQ; Chopra AK
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5034-42. PubMed ID: 21859946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the effectiveness of antibacterial substances in treating an experimental form of bubonic plague in monkeys].
    Romanov VE; Evstigneev VI; Vasil'ev NT; Shabalin BA; Paramonov VE
    Antibiot Khimioter; 2001; 46(8):6-8. PubMed ID: 11871319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.